annual CFI:
-$88.76M-$338.06M(-135.60%)Summary
- As of today (June 28, 2025), DNLI annual cash flow from investing activities is -$88.76 million, with the most recent change of -$338.06 million (-135.60%) on December 31, 2024.
- During the last 3 years, DNLI annual CFI has fallen by -$67.13 million (-310.41%).
- DNLI annual CFI is now -135.60% below its all-time high of $249.31 million, reached on December 31, 2023.
Performance
DNLI Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$18.75M-$153.46M(-89.11%)Summary
- As of today (June 28, 2025), DNLI quarterly cash flow from investing activities is $18.75 million, with the most recent change of -$153.46 million (-89.11%) on March 31, 2025.
- Over the past year, DNLI quarterly CFI has increased by +$471.94 million (+104.14%).
- DNLI quarterly CFI is now -89.11% below its all-time high of $172.21 million, reached on December 31, 2024.
Performance
DNLI quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$383.18M+$471.94M(+531.72%)Summary
- As of today (June 28, 2025), DNLI TTM cash flow from investing activities is $383.18 million, with the most recent change of +$471.94 million (+531.72%) on March 31, 2025.
- Over the past year, DNLI TTM CFI has increased by +$494.34 million (+444.70%).
- DNLI TTM CFI is now at all-time high.
Performance
DNLI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
DNLI Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -135.6% | +104.1% | +444.7% |
| 3 y3 years | -310.4% | +115.9% | +435.8% |
| 5 y5 years | -160.1% | +240.6% | +169.0% |
DNLI Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -135.6% | +37.2% | -89.1% | +104.1% | at high | +303.9% |
| 5 y | 5-year | -135.6% | +85.8% | -89.1% | +104.1% | at high | +160.3% |
| alltime | all time | -135.6% | +85.8% | -89.1% | +104.1% | at high | +160.3% |
DNLI Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $18.75M(-89.1%) | $383.18M(-531.7%) |
| Dec 2024 | -$88.76M(-135.6%) | $172.21M(+83.9%) | -$88.76M(-52.8%) |
| Sep 2024 | - | $93.66M(-5.0%) | -$187.92M(+4.0%) |
| Jun 2024 | - | $98.57M(-121.8%) | -$180.66M(+62.5%) |
| Mar 2024 | - | -$453.19M(-720.4%) | -$111.16M(-144.6%) |
| Dec 2023 | $249.31M(-276.3%) | $73.05M(-27.6%) | $249.31M(+411.9%) |
| Sep 2023 | - | $100.91M(-40.0%) | $48.70M(-232.4%) |
| Jun 2023 | - | $168.07M(-281.3%) | -$36.79M(-68.3%) |
| Mar 2023 | - | -$92.72M(-27.3%) | -$116.22M(-17.8%) |
| Dec 2022 | -$141.39M(+553.8%) | -$127.56M(-927.3%) | -$141.39M(+159.1%) |
| Sep 2022 | - | $15.42M(-82.6%) | -$54.58M(-55.6%) |
| Jun 2022 | - | $88.63M(-175.2%) | -$123.00M(+7.8%) |
| Mar 2022 | - | -$117.88M(+189.3%) | -$114.10M(+427.6%) |
| Dec 2021 | -$21.63M(-96.5%) | -$40.75M(-23.1%) | -$21.63M(-93.8%) |
| Sep 2021 | - | -$53.01M(-154.3%) | -$348.22M(-31.4%) |
| Jun 2021 | - | $97.54M(-483.9%) | -$507.33M(-20.1%) |
| Mar 2021 | - | -$25.41M(-93.1%) | -$635.28M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$623.21M(-521.9%) | -$367.34M(+73.2%) | -$623.21M(+191.9%) |
| Sep 2020 | - | -$212.12M(+597.5%) | -$213.48M(-543.5%) |
| Jun 2020 | - | -$30.41M(+128.1%) | $48.13M(-66.2%) |
| Mar 2020 | - | -$13.33M(-131.5%) | $142.43M(-3.6%) |
| Dec 2019 | $147.71M(-151.4%) | $42.38M(-14.4%) | $147.71M(+236.3%) |
| Sep 2019 | - | $49.49M(-22.5%) | $43.92M(+12.2%) |
| Jun 2019 | - | $63.88M(-893.8%) | $39.16M(+574.6%) |
| Mar 2019 | - | -$8.05M(-86.9%) | $5.80M(-102.0%) |
| Dec 2018 | -$287.42M(+598.2%) | -$61.40M(-237.3%) | -$287.42M(-10.5%) |
| Sep 2018 | - | $44.73M(+46.5%) | -$321.17M(-8.1%) |
| Jun 2018 | - | $30.53M(-110.1%) | -$349.37M(-2.4%) |
| Mar 2018 | - | -$301.27M(+216.6%) | -$357.82M(+769.2%) |
| Dec 2017 | -$41.17M(-81.2%) | -$95.15M(-675.8%) | -$41.17M(-176.3%) |
| Sep 2017 | - | $16.53M(-25.1%) | $53.98M(+44.1%) |
| Jun 2017 | - | $22.07M(+43.5%) | $37.46M(+143.5%) |
| Mar 2017 | - | $15.38M | $15.38M |
| Dec 2016 | -$219.00M(+7052.3%) | - | - |
| Dec 2015 | -$3.06M | - | - |
FAQ
- What is Denali Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Denali Therapeutics?
- What is Denali Therapeutics annual CFI year-on-year change?
- What is Denali Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Denali Therapeutics?
- What is Denali Therapeutics quarterly CFI year-on-year change?
- What is Denali Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Denali Therapeutics?
- What is Denali Therapeutics TTM CFI year-on-year change?
What is Denali Therapeutics annual cash flow from investing activities?
The current annual CFI of DNLI is -$88.76M
What is the all time high annual CFI for Denali Therapeutics?
Denali Therapeutics all-time high annual cash flow from investing activities is $249.31M
What is Denali Therapeutics annual CFI year-on-year change?
Over the past year, DNLI annual cash flow from investing activities has changed by -$338.06M (-135.60%)
What is Denali Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of DNLI is $18.75M
What is the all time high quarterly CFI for Denali Therapeutics?
Denali Therapeutics all-time high quarterly cash flow from investing activities is $172.21M
What is Denali Therapeutics quarterly CFI year-on-year change?
Over the past year, DNLI quarterly cash flow from investing activities has changed by +$471.94M (+104.14%)
What is Denali Therapeutics TTM cash flow from investing activities?
The current TTM CFI of DNLI is $383.18M
What is the all time high TTM CFI for Denali Therapeutics?
Denali Therapeutics all-time high TTM cash flow from investing activities is $383.18M
What is Denali Therapeutics TTM CFI year-on-year change?
Over the past year, DNLI TTM cash flow from investing activities has changed by +$494.34M (+444.70%)